BRIGHT MINDS BIOSCIENCES INC.
For the period ended Mar 31, 2026. Filed May 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Mar 31, 2026 · Filed May 20, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.2 · Difficulties with Forecasts
Difficulties with Forecasts
The Company must rely largely on its own market research to forecast sales as detailed forecasts are not generally obtainable from other sources at this early stage of the pharmaceutical industry in Canada. A failure in the demand for its products and services to materialize as a result of competition, technological change or other factors could have a material adverse effect on the business, results of operations and financial condition of the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.